Home/Filings/4/0001225208-22-003862
4//SEC Filing

Meredith Ian T 4

Accession 0001225208-22-003862

CIK 0000885725other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 4:27 PM ET

Size

8.0 KB

Accession

0001225208-22-003862

Insider Transaction Report

Form 4
Period: 2022-02-28
Meredith Ian T
EVP/ Global Chief Medical Offi
Transactions
  • Tax Payment

    Common Stock

    2022-02-28$44.17/sh300$13,25134,670 total
  • Exercise/Conversion

    Common Stock

    2022-02-28+1,01934,970 total
  • Exercise/Conversion

    Deferred Stock Units

    2022-02-281,0190 total
    Exp: 2022-02-28Common Stock (1,019 underlying)
Footnotes (2)
  • [F1]Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
  • [F2]Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant.

Documents

1 file

Issuer

BOSTON SCIENTIFIC CORP

CIK 0000885725

Entity typeother

Related Parties

1
  • filerCIK 0001693920

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:27 PM ET
Size
8.0 KB